Losartan Potassium
Product Images NDC 50090-2882

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-2882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500902622)

FDA Label Image

Label Image (Lbl500902656)

FDA Label Image

Label Image (Lbl500902882)

Label Image (Lbl500902882)
This appears to be a medication or supplement containing 50mg of potassium, labeled as "TolarTaN". It comes in a bottle containing 30 tablets with a note regarding the product code "i53-0" and "1mc, zotpe". The label also includes information about the pH level ("STonE AT 6.0 7") and possibly a note about being free of something ("FRTEE o").*
FDA Label Image

Figure1 (Losartan Fig1)

Figure1 (Losartan Fig1)
The text appears to be a partial data display of a medical study involving two drugs, Atenolol and Losartan Potassium. The information shown includes the adjusted risk reduction percentage and the study timeline in months. However, without further context or details, it is difficult to provide a specific description or conclusion about the study's findings.*
FDA Label Image

Figure2 (Losartan Fig2)

FDA Label Image

Figure 3 (Losartan Fig3)

Figure 3 (Losartan Fig3)
This appears to be a table or figure displaying the number of primary endpoint events within demographic subgroups. It includes data on age, gender, race, and a history of VD, but the context and larger purpose of the figure or study are not available.*
FDA Label Image

Figure-4 (Losartan Fig4)

Figure-4 (Losartan Fig4)
The text appears to be a comparison of patients taking Losttan Potassium versus placebo. It provides the percentage of patients with an event, the risk reduction percentage, and the p-value for the comparison. However, without additional context, it is not possible to determine what type of event or condition is being studied.*
FDA Label Image

Chemical Structure (Losartan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.